Editing CUA: Neurogenic Lower Urinary Tract Dysfunction (2019) (section)

== Risk classification for urological morbidity in NLUTD ==
{| class="wikitable"
|'''<span style="color:#ff0000">Risk group'''
|'''<span style="color:#ff0000">Description'''
|-
|'''<span style="color:#ff0000">High-risk'''
|
* '''<span style="color:#ff0000">Underlying high-risk disease (SCI, spina bifida, advanced MS) OR select other neurogenic diseases with evidence of significant urological complications or morbidity'''
* '''<span style="color:#ff0000">With any high-risk feature(4):'''
*# '''<span style="color:#ff0000">Bladder management technique: Valsalva/crede/reflexive voiding; or'''
*# '''<span style="color:#ff0000">UDS: Known high-risk features on UDS without confirmation of appropriate attenuation after treatment (DSD, NDO, impaired compliance [<20 ml/cm H2O], DLPP >40 cm H2O, vesico-ureteral reflex); or'''
*# '''<span style="color:#ff0000">Imaging: new/worsening renal imaging (hydronephrosis, atrophy, scarring); or'''
*# '''<span style="color:#ff0000">Renal function: new/worsening renal insufficiency'''
|-
|'''<span style="color:#ff0000">Moderate-risk'''
|
* '''Underlying high-risk disease (SCI, spina bifida, advanced MS) OR select other neurogenic diseases with evidence of significant urological complications or morbidity'''
* '''With ANY feature such as:'''
*# '''Bladder management technique: clean intermittent catheterization, spontaneous voiding, indwelling catheter or'''
*# '''UDS: Prior history of high-risk features on UDS (see above) that have been appropriately optimized; or'''
*# '''Imaging: no significant change or'''
*# '''Renal function: no significant change'''
|-
|'''<span style="color:#ff0000">Low-risk'''
|'''No evidence of high-risk disease/features on initial evaluation'''
|}

* '''<span style="color:#ff0000">Other indicators of potentially higher risk of urological morbidity in NLUTD patients (3):'''
** '''<span style="color:#ff0000">Imaging demonstrating'''
*** '''<span style="color:#ff0000">Stone disease'''
*** '''<span style="color:#ff0000">Abnormal bladder morphology'''
** '''<span style="color:#ff0000">SCI patients with autonomic dysreflexia associated with bladder dysfunction'''
* '''<span style="color:#ff0000">Patients with SCI, spina bifida, or advanced MS without high-risk features are considered moderate-risk'''